Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
EHC

Encompass Health Corp

EHC

64.76USD-0.23 (-0.35%)Market Closed
Watchlist

Market Summary

USD64.76-0.23
Market Closed
-0.35%

EHC Alerts

  • 1 major insider sales recently.
  • Big jump in Earnings (Y/Y)

EHC Stock Price

View Fullscreen

EHC RSI Chart

EHC Alerts

EHC Valuation

Market Cap

6.4B

Price/Earnings (Trailing)

18.21

Price/Sales (Trailing)

1.37

EV/EBITDA

8.98

Price/Free Cashflow

50.94

EHC Price/Sales (Trailing)

EHC Profitability

EBT Margin

12.65%

Return on Equity

16.47%

Return on Assets

5.93%

Free Cashflow Yield

1.96%

EHC Fundamentals

EHC Revenue

Revenue (TTM)

4.7B

Revenue Y/Y

10.78%

Revenue Q/Q

1.67%

EHC Earnings

Earnings (TTM)

353.8M

Earnings Y/Y

87.89%

Earnings Q/Q

-6.67%

Price Action

Last 7 days

-2.5%

Last 30 days

1.1%

Last 90 days

-7.1%

Trailing 12 Months

13.6%

How does EHC drawdown profile look like?

EHC Financial Health

Current Ratio

1.27

Debt/Equity

1.25

Debt/Cashflow

0.25

EHC Investor Care

Dividend Yield

0.93%

Dividend/Share (TTM)

0.6

Shares Dilution (1Y)

0.30%

Diluted EPS (TTM)

3.5

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20234.4B4.6B4.7B0
20224.1B4.2B4.3B4.3B
20214.4B4.3B4.2B4.0B
20204.7B4.6B4.6B4.6B
20194.4B4.4B4.5B4.6B
20184.0B4.1B4.2B4.3B
20173.8B3.8B3.9B3.9B
20163.3B3.5B3.6B3.7B
20152.6B2.7B2.9B3.2B
20142.3B2.3B2.4B2.4B
20132.2B2.2B2.3B2.3B
20122.1B2.1B2.1B2.2B
20111.9B2.0B2.0B2.0B
20101.8B1.8B1.7B1.9B
20091.8B1.8B1.8B1.8B
20080001.8B
Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for EHC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 27, 2023
christie edward m iii
acquired
-
-
997
-
Nov 13, 2023
coltharp douglas e
acquired
441,341
26.55
16,623
evp & chief financial officer
Nov 13, 2023
coltharp douglas e
sold
-710,919
63.39
-11,215
evp & chief financial officer
Oct 17, 2023
reidy christopher r
acquired
258
64.5
4.00
-
Oct 17, 2023
chidsey john
acquired
34,937
64.58
541
-
Oct 16, 2023
maryland patricia anne
acquired
-
-
27.00
-
Oct 16, 2023
williams terrance
acquired
-
-
27.00
-
Oct 16, 2023
herman joan e
acquired
-
-
101
-
Oct 16, 2023
reidy christopher r
acquired
-
-
16.00
-
Oct 16, 2023
chidsey john
acquired
-
-
222
-

1–10 of 50

Which funds bought or sold EHC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-24.78
-270,163
793,831
 -%
Nov 24, 2023
DEUTSCHE BANK AG\
added
34.25
354,059
1,421,710
 -%
Nov 22, 2023
KBC Group NV
unchanged
-
-
19,000
 -%
Nov 21, 2023
Walleye Capital LLC
new
-
48,422
48,422
 -%
Nov 21, 2023
COMERICA BANK
added
8.29
9,095,440
9,097,440
 0.05%
Nov 21, 2023
Walleye Trading LLC
added
4.35
4,034
119,276
 -%
Nov 17, 2023
TimesSquare Capital Management, LLC
reduced
-0.91
-1,140,000
65,474,000
 1.02%
Nov 17, 2023
OLD NATIONAL BANCORP /IN/
reduced
-1.03
-48,952
2,620,580
 0.08%
Nov 16, 2023
McIlrath & Eck, LLC
unchanged
-
-20.00
2,485
 -%
Nov 16, 2023
Financial Gravity Asset Management, Inc.
reduced
-89.71
418
520
 -%

1–10 of 43

Latest Funds Activity

Are funds buying EHC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own EHC
No. of Funds

Schedule 13G FIlings of Encompass Health Corp

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
9.77%
9,749,441
SC 13G/A
Feb 06, 2023
wellington management group llp
9.58%
9,558,849
SC 13G/A
Jan 30, 2023
blackrock inc.
11.3%
11,232,620
SC 13G/A
Jan 30, 2023
blackrock inc.
11.3%
11,232,620
SC 13G/A
Feb 10, 2022
vanguard group inc
9.46%
9,414,569
SC 13G/A
Feb 04, 2022
wellington management group llp
10.58%
10,524,661
SC 13G/A
Jan 27, 2022
blackrock inc.
10.7%
10,643,463
SC 13G/A
Jan 25, 2022
blackrock inc.
10.7%
10,643,463
SC 13G/A
Feb 11, 2021
william blair investment management, llc
4.70%
4,666,500
SC 13G/A
Feb 10, 2021
vanguard group inc
9.05%
8,998,232
SC 13G/A

Recent SEC filings of Encompass Health Corp

View All Filings
Date Filed Form Type Document
Nov 28, 2023
3
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 27, 2023
8-K
Current Report
Nov 14, 2023
4
Insider Trading
Nov 13, 2023
144
Notice of Insider Sale Intent
Nov 01, 2023
10-Q
Quarterly Report
Oct 31, 2023
S-3ASR
S-3ASR
Oct 26, 2023
8-K
Current Report
Oct 17, 2023
4
Insider Trading
Oct 17, 2023
4
Insider Trading

EHC Fair Value

Loading...

Peers (Alternatives to Encompass Health Corp)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
UNH
508.7B
360.0B
 2.46% 0.72%
23.46
1.41
 14.24% 11.62%
CVS
96.7B
347.8B
 9.25% -26.74%
11.1
0.28
 10.34% 159.11%
CI
91.1B
189.9B
 -12.37% -22.06%
13.64
1.92
 5.24% 22.27%
HCA
69.2B
63.2B
 11.16% 6.57%
12.11
1.1
 5.62% 6.32%
CNC
39.4B
150.1B
 4.91% -14.72%
16.13
0.26
 6.04% 21.35%
MID-CAP
DVA
9.8B
11.9B
 26.82% 43.59%
16.13
0.82
 2.36% -10.41%
UHS
9.6B
14.0B
 6.07% 6.08%
14.25
0.69
 6.03% -8.61%
CHE
8.6B
2.2B
 -1.60% 9.83%
35.34
3.88
 4.50% -6.69%
ACHC
6.7B
2.9B
 -0.53% -12.01%
-365.93
2.34
 13.16% -106.47%
AMN
2.6B
4.1B
 13.56% -40.93%
9.25
0.63
 -25.26% -41.25%
SMALL-CAP
AMEH
1.6B
1.3B
 4.12% 12.39%
34.86
1.17
 27.06% -27.04%
ADUS
1.5B
1.0B
 10.48% -13.37%
25.78
1.44
 10.84% 30.19%
BKD
1.0B
3.0B
 22.30% 77.33%
-8.11
0.34
 6.98% 58.07%
BEAT
35.8M
-
 8.80% -76.75%
-2.47
-
 - -27.68%
AMS
15.8M
20.7M
 12.00% -11.27%
54.39
0.76
 6.53% -78.75%

Encompass Health Corp News

Latest updates
Stocks Register • 09 Dec 2023 • 03:02 pm • 7 hours ago
Encompass Health Corp (EHC): A New Perspective – Stocks Register
Nasdaq • 29 Nov 2023 • 03:00 pm • 10 days ago
Validea's Top Health Care Stocks Based On Martin Zweig - 11/29 ...
Yahoo Finance • 26 Oct 2023 • 07:00 am • 44 days ago
Encompass Health Corp (EHC) Reports Q3 2023 Earnings, Updates ...
PR Newswire • 19 Oct 2023 • 07:00 am • 51 days ago
Encompass Health declares dividend on common stock
PR Newswire • 12 Sep 2023 • 07:00 am • 2 months ago
Rehabilitation Hospital of Columbus, a 40-bed inpatient ...
Business Insider • 24 Aug 2023 • 07:00 am • 3 months ago
Goldman Sachs: 50 Stocks to Be Long-Term Beneficiaries of AI
Hospice News • 23 Aug 2023 • 07:00 am • 3 months ago
Enhabit Begins Mulling Strategic Alternatives, Possible Sale
Benzinga • 22 Aug 2023 • 07:00 am • 3 months ago
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor - Encompass Health (NYSE:
Hospice News • 10 Aug 2023 • 07:00 am • 4 months ago
'Progress Has Not Been Fast Enough': Enhabit Reveals Plans to ...
PR Newswire • 01 Aug 2023 • 07:00 am • 4 months ago
Encompass Health reports results for second quarter 2023
PR Newswire • 18 Jul 2023 • 07:00 am • 4 months ago
Encompass Health to host investor day September 27, 2023
Business Insider • 11 Jul 2023 • 07:00 am • 5 months ago
29 Top Stock Picks for the Next 12 Months: Deutsche Bank
KTAR.com • 09 Jul 2023 • 07:00 am • 5 months ago
Mixed-use project with housing, retail, medical planned in Avondale
Reuters • 13 Jun 2023 • 07:00 am • 5 months ago
Exclusive: Arex Capital pushes Enhabit to consider company sale
PR Newswire • 13 Jun 2023 • 07:00 am • 5 months ago
Rehabilitation Hospital of Bowie, a 60-bed inpatient rehabilitation ...

Financials for Encompass Health Corp

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue1.7%1,2071,1871,1601,1371,0901,0631,0591,0431,0111,0029601,2141,1741,0741,1821,1841,1621,1351,1241,0961,068
Costs and Expenses2.4%1,0281,0039829589419139076568441,0691,02361.001,0019751,0021,022990965937985895
  S&GA Expenses-10.1%50.0055.0043.0043.0038.0036.0037.0042.0039.0054.0039.0034.0039.0043.0036.0064.0053.0077.0053.0054.0050.00
EBITDA Margin1.6%0.21*0.21*0.21*0.20*0.21*0.19*0.20*0.21*0.22*0.22*0.20*0.19*0.19*0.19*0.20*------
Interest Expenses-1.1%36.0036.0036.0038.0038.0060.0040.0040.0040.0042.0043.0046.0049.0046.0043.0045.0040.0038.0037.0037.0037.00
Income Taxes-7.6%30.0033.0032.0032.0022.0023.0024.0023.0026.0028.0025.0038.0027.0012.0027.0027.0034.0024.0031.0029.0030.00
Earnings Before Taxes-4.1%14515114615110783.0011071.0012818216730.0012760.0013611815413515776.00140
EBT Margin4.1%0.13*0.12*0.11*0.10*0.11*0.11*0.12*0.13*0.13*0.13*0.11*0.10*0.10*0.10*0.12*------
Net Income-6.7%85.0091.0088.0089.0045.0049.0088.0092.0010011310786.0078.0034.0087.0068.0098.0091.0010228.0089.00
Net Income Margin9.9%0.08*0.07*0.06*0.06*0.06*0.06*0.08*0.08*0.08*0.08*0.06*0.06*0.06*0.06*0.07*------
Free Cashflow-33.0%60.0090.00131-17.70-74.80130104-68.8054.0014260.0014084.00139-54.20------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets1.8%5,9645,8615,7475,6375,4767,0826,9446,8656,7226,6136,5426,4466,6116,5036,1386,0816,3875,8125,5845,1755,132
  Current Assets-1.2%8148247627177341,0329509219108591,0019491,1741,1027857561,077845683662638
    Cash Equivalents-15.1%10011885.0022.0060.0013677.0049.0066.0073.0022418645041910560.0042222256.0069.0057.00
  Net PPE-------------2,0952,0412,0031,9591,8751,7881,7361,6351,591
  Goodwill0.8%1,2811,2718.001,2631,2472,4572,4571,2372,4182,4122,3191,2282,3192,3192,3121,2192,3052,1122,1122,1012,081
Liabilities-0.8%3,7753,8043,7843,7753,7284,5384,4524,4664,4284,4044,4684,4444,6814,6384,3074,1484,5063,8763,6943,3563,312
  Current Liabilities-2.4%6396555925766058357557497948058127176836645867211,109753768673610
  Long Term Debt-0.2%2,6932,6982,7232,7422,7193,2343,2213,2413,1423,1063,1603,2513,5393,5473,3223,0232,9622,7202,5222,4792,504
Shareholder's Equity45.6%2,1481,4751,9261,3101,2172,5012,4482,3572,2612,1762,0431,9701,8961,8311,7971,6931,6711,5841,6171,5571,544
  Retained Earnings----116---142----242----526----885-
  Additional Paid-In Capital----1,730---2,290---2,327---2,370---2,589-
Shares Outstanding-100.0%-10099.00-99.0099.0099.00-99.0099.00124-124124123-123123124-123
Minority Interest8.3%587542542516493498475446418414388382375369353341338308302280265
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-9.3%206,700,000227,900,000172,200,00070,100,000244,600,000218,900,000123,800,000177,600,000255,900,000158,500,000279,700,000173,400,000222,300,00029,300,000215,600,000114,400,000145,400,000159,900,000178,400,000198,500,000169,200,000
  Share Based Compensation97.5%15,600,0007,900,0008,100,0007,300,0007,700,0006,100,0009,500,0004,800,00012,000,0002,800,000300,0008,300,0009,900,0007,100,00027,400,00021,700,00045,900,00019,400,00020,300,00018,100,00021,400,000
Cashflow From Investing-23.6%-128,500,000-104,000,000-206,400,000-174,300,000-123,200,000-123,100,000-220,700,000-124,000,000-226,000,000-95,600,000-142,700,000-89,700,000-92,100,000-83,000,000-145,700,000-320,100,000-100,100,000-91,500,000-98,200,000-65,300,000-200,400,000
Cashflow From Financing25.0%-43,500,000-58,000,000-16,500,000-49,000,000-19,300,000-60,900,00042,300,000-18,500,000-186,400,000-77,500,000-354,200,000-45,600,000182,800,00071,100,000-424,100,000431,800,000122,200,000-81,700,000-67,700,000-137,000,000200,000
  Dividend Payments-4.5%14,900,00015,600,00014,900,00027,800,00027,800,00028,500,00027,700,00027,600,00027,800,00029,100,00027,500,00027,600,00027,700,00029,000,00027,400,00026,400,00026,600,00028,300,00026,400,00024,500,00024,500,000
  Buy Backs-----------1,200,000----2,100,000-----

EHC Income Statement

2023-09-30
Condensed Consolidated Statements of Comprehensive Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement Of Comprehensive Income And Income Statement [Abstract]    
Net operating revenues$ 1,206.9$ 1,089.5$ 3,554.4$ 3,211.3
Operating expenses:    
Salaries and benefits658.6605.61,923.81,778.9
Other operating expenses183.7172.0534.3500.3
Occupancy costs14.212.442.341.6
Supplies53.951.1159.7148.2
General and administrative expenses49.837.9148.6111.5
Depreciation and amortization67.362.1203.8180.3
Total operating expenses1,027.5941.13,012.52,760.8
Loss on early extinguishment of debt0.00.00.01.4
Interest expense and amortization of debt discounts and fees35.938.2108.6138.2
Other (income) expense(0.5)3.6(6.8)13.6
Equity in net income of nonconsolidated affiliates(1.0)(0.7)(2.3)(2.6)
Income from continuing operations before income tax expense145.0107.3442.4299.9
Provision for income tax expense30.321.895.068.2
Income from continuing operations114.785.5347.4231.7
(Loss) income from discontinued operations, net of tax(1.3)(18.5)(3.5)16.7
Net and comprehensive income113.467.0343.9248.4
Net and comprehensive income113.467.0343.9248.4
Less: Net income attributable to noncontrolling interests included in continuing operations(28.1)(21.6)(79.5)(65.5)
Less: Net income attributable to noncontrolling interests included in discontinued operations0.00.00.0(1.3)
Less: Net and comprehensive income attributable to noncontrolling interests(28.1)(21.6)(79.5)(66.8)
Less: Net and comprehensive income attributable to noncontrolling interests(28.1)(21.6)(79.5)(66.8)
Net and comprehensive income attributable to Encompass Health85.345.4264.4181.6
Net and comprehensive income attributable to Encompass Health$ 85.3$ 45.4$ 264.4$ 181.6
Weighted average common shares outstanding:    
Basic (in shares)99.599.299.599.2
Diluted (in shares)101.4100.5101.1100.3
Basic earnings per share attributable to Encompass Health common shareholders:    
Continuing operations (in dollars per share)$ 0.86$ 0.64$ 2.68$ 1.67
Discontinued operations (in dollars per share)(0.01)(0.19)(0.04)0.15
Net income (in dollars per share)0.850.452.641.82
Diluted earnings per share attributable to Encompass Health common shareholders:    
Continuing operations (in dollars per share)0.850.632.651.66
Discontinued operations (in dollars per share)(0.01)(0.18)(0.03)0.15
Net income (in dollars per share)$ 0.84$ 0.45$ 2.62$ 1.81
Amounts attributable to Encompass Health common shareholders:    
Income from continuing operations$ 86.6$ 63.9$ 267.9$ 166.2
(Loss) income from discontinued operations, net of tax(1.3)(18.5)(3.5)15.4
Net and comprehensive income attributable to Encompass Health$ 85.3$ 45.4$ 264.4$ 181.6

EHC Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 99.7$ 21.8
Restricted cash41.531.6
Accounts receivable535.9536.8
Other current assets136.6127.0
Total current assets813.7717.2
Property and equipment, net3,186.32,939.2
Operating lease right-of-use assets196.8212.5
Goodwill1,281.31,263.2
Intangible assets, net276.4282.3
Other long-term assets209.8222.1
Total assets[1]5,964.35,636.5
Current liabilities:  
Current portion of long-term debt23.925.2
Current operating lease liabilities24.925.6
Accounts payable165.4132.9
Accrued expenses and other current liabilities425.0392.2
Total current liabilities639.2575.9
Long-term debt, net of current portion2,692.72,741.8
Long-term operating lease liabilities183.9199.7
Deferred income tax liabilities80.483.0
Other long-term liabilities178.9174.2
Total liabilities3,775.13,774.6
Commitments and contingencies
Redeemable noncontrolling interests41.535.6
Shareholders’ equity:  
Encompass Health shareholders’ equity1,560.41,310.3
Noncontrolling interests587.3516.0
Total shareholders’ equity2,147.71,826.3
Total liabilities and shareholders' equity[1]$ 5,964.3$ 5,636.5
[1]Our consolidated assets as of September 30, 2023 and December 31, 2022 include total assets of variable interest entities of $204.2 million and $207.8 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of September 30, 2023 and December 31, 2022 include total liabilities of the variable interest entities of $41.7 million and $47.9 million, respectively. See Note 4, Variable Interest Entities.

About Encompass Health Corp

EHC
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
 CEO
 WEBSITEwww.encompasshealth.com
 EMPLOYEES36900

Encompass Health Corp Frequently Asked Questions

What is the ticker symbol for Encompass Health Corp? What does EHC stand for in stocks?

EHC is the stock ticker symbol of Encompass Health Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Encompass Health Corp (EHC)?

As of Fri Dec 08 2023, market cap of Encompass Health Corp is 6.44 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EHC stock?

You can check EHC's fair value in chart. The fair value of Encompass Health Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Encompass Health Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Encompass Health Corp a good stock to buy?

The fair value guage provides a quick view whether EHC is over valued or under valued. Whether Encompass Health Corp is cheap or expensive depends on the assumptions which impact Encompass Health Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EHC.

What is Encompass Health Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, EHC's PE ratio (Price to Earnings) is 18.21 and Price to Sales (PS) ratio is 1.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EHC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Encompass Health Corp's stock?

In the past 10 years, Encompass Health Corp has provided 0.104 (multiply by 100 for percentage) rate of return.